Monash University Discovery Uncovers Clue to Disarm Gonorrhea Superbug

Article

Every year, more than 100 million people worldwide develop the sexually transmitted disease gonorrhea, with health consequences such as infertility, transmission of the disease to newborn babies, and increased risk of HIV infections. There has been a 63 percent rise in gonorrhea in Australia over the past five years.

Gonorrhoea is caused by bacteria which can rapidly develop resistance to all known antibiotics -- commonly called 'superbugs.' Gonorrhea superbugs have now been detected in every Australian state and territory and are increasingly difficult to treat in the clinic.

Monash University researchers have discovered a way the gonorrhoea bacteria cleverly evade the immune system - opening up the way for therapies that prevent this process, allowing the body's natural defences to kill the bug.

Published today in PLOS Pathogens, Dr. Thomas Naderer and Dr. Pankaj Deo and their team from the Monash Biomedicine Discovery Institute, have discovered how the gonorrhea-causing superbug (which is very small) creates even smaller packages of bacterial membrane blebs, termed vesicles, which attack immune cells.

Using cutting-edge super-resolution microscopy, which is able to see, and film, the most minute of events - the researchers found that these membrane vesicles interacted with the cells in the human immune system called 'macrophages', triggering these to die in an orchestrated suicide process. Macrophages are the cells within the immune system that ordinarily kill foreign invaders like bacteria and viruses, so without them the gonorrhoea bacteria can flourish.

Naderer said that this new understanding of how the gonorrhea bacteria interact and cause the death of immune system cells "may lead to strategies to combat gonorrhea infection and its symptoms".

The research may also provide information as to how other bacteria evade the immune system and be unaffected by antibiotics. The 2016 Review on Antimicrobial Resistance Final Report and Recommendations states that antibiotic resistant infection will kill an extra 10 million people a year worldwide - more than currently die from cancer - by 2050 unless action is taken.

Source: Monash Biomedicine Discovery Institute

Recent Videos
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Related Content